Titre : Virus oncolytiques

Virus oncolytiques : Questions médicales fréquentes

Termes MeSH sélectionnés :

Models, Biological

Questions fréquentes et termes MeSH associés

Général 1

#1

Erreur lors de la génération.

Veuillez réessayer ultérieurement.
Oncolytic Viruses
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Virus oncolytiques : Questions médicales les plus fréquentes", "headline": "Virus oncolytiques : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Virus oncolytiques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-20", "dateModified": "2025-11-11", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Virus oncolytiques" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Virus", "url": "https://questionsmedicales.fr/mesh/D014780", "about": { "@type": "MedicalCondition", "name": "Virus", "code": { "@type": "MedicalCode", "code": "D014780", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B04" } } }, "about": { "@type": "MedicalCondition", "name": "Virus oncolytiques", "alternateName": "Oncolytic Viruses", "code": { "@type": "MedicalCode", "code": "D050504", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Grant McFadden", "url": "https://questionsmedicales.fr/author/Grant%20McFadden", "affiliation": { "@type": "Organization", "name": "Center for Immunotherapy, Vaccines and Virotherapy, Biodesign Institute, Arizona State University, Tempe, AZ 85287, USA." } }, { "@type": "Person", "name": "Masmudur M Rahman", "url": "https://questionsmedicales.fr/author/Masmudur%20M%20Rahman", "affiliation": { "@type": "Organization", "name": "Center for Immunotherapy, Vaccines and Virotherapy, Biodesign Institute, Arizona State University, Tempe, AZ 85287, USA." } }, { "@type": "Person", "name": "Ting Ye", "url": "https://questionsmedicales.fr/author/Ting%20Ye", "affiliation": { "@type": "Organization", "name": "Zhejiang Sci-Tech University Hangzhou Gongchu Joint Institute of Biomedicine, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018, China. yeting@zstu.edu.cn." } }, { "@type": "Person", "name": "Gongchu Li", "url": "https://questionsmedicales.fr/author/Gongchu%20Li", "affiliation": { "@type": "Organization", "name": "Zhejiang Sci-Tech University Hangzhou Gongchu Joint Institute of Biomedicine, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018, China. lgc@zstu.edu.cn." } }, { "@type": "Person", "name": "Howard L Kaufman", "url": "https://questionsmedicales.fr/author/Howard%20L%20Kaufman", "affiliation": { "@type": "Organization", "name": "Harvard Medical School, Harvard University, Boston, MA, USA. HLKaufman@mgh.harvard.edu." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Integrodifference models for evolutionary processes in biological invasions.", "datePublished": "2023-06-17", "url": "https://questionsmedicales.fr/article/37330418", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00285-023-01947-z" } }, { "@type": "ScholarlyArticle", "name": "Stochastic models of regulation of transcription in biological cells.", "datePublished": "2023-09-29", "url": "https://questionsmedicales.fr/article/37775568", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00285-023-01998-2" } }, { "@type": "ScholarlyArticle", "name": "Biology System Description Language (BiSDL): a modeling language for the design of multicellular synthetic biological systems.", "datePublished": "2024-04-25", "url": "https://questionsmedicales.fr/article/38664639", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12859-024-05782-x" } }, { "@type": "ScholarlyArticle", "name": "A Continuation Technique for Maximum Likelihood Estimators in Biological Models.", "datePublished": "2023-08-31", "url": "https://questionsmedicales.fr/article/37650951", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s11538-023-01200-0" } }, { "@type": "ScholarlyArticle", "name": "Studies of Endocrine Disruptors: Nonylphenol and Isomers in Biological Models.", "datePublished": "2023-05-22", "url": "https://questionsmedicales.fr/article/37057841", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/etc.5633" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Virus", "item": "https://questionsmedicales.fr/mesh/D014780" }, { "@type": "ListItem", "position": 3, "name": "Virus oncolytiques", "item": "https://questionsmedicales.fr/mesh/D050504" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Virus oncolytiques - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Virus oncolytiques", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2026-02-06", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Général", "headline": "Général sur Virus oncolytiques", "description": "Erreur lors de la génération.", "url": "https://questionsmedicales.fr/mesh/D050504?mesh_terms=Models,+Biological#section-général" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Erreur lors de la génération.", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Veuillez réessayer ultérieurement." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 11/11/2025

Contenu vérifié selon les dernières recommandations médicales

Auteurs principaux

Grant McFadden

5 publications dans cette catégorie

Affiliations :
  • Center for Immunotherapy, Vaccines and Virotherapy, Biodesign Institute, Arizona State University, Tempe, AZ 85287, USA.
Publications dans "Virus oncolytiques" :

Masmudur M Rahman

4 publications dans cette catégorie

Affiliations :
  • Center for Immunotherapy, Vaccines and Virotherapy, Biodesign Institute, Arizona State University, Tempe, AZ 85287, USA.
Publications dans "Virus oncolytiques" :

Ting Ye

3 publications dans cette catégorie

Affiliations :
  • Zhejiang Sci-Tech University Hangzhou Gongchu Joint Institute of Biomedicine, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018, China. yeting@zstu.edu.cn.
Publications dans "Virus oncolytiques" :

Gongchu Li

3 publications dans cette catégorie

Affiliations :
  • Zhejiang Sci-Tech University Hangzhou Gongchu Joint Institute of Biomedicine, College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018, China. lgc@zstu.edu.cn.
Publications dans "Virus oncolytiques" :

Howard L Kaufman

3 publications dans cette catégorie

Affiliations :
  • Harvard Medical School, Harvard University, Boston, MA, USA. HLKaufman@mgh.harvard.edu.
  • Division of Head and Neck Surgical Oncology, Department of Otolaryngology, Massachusetts Eye and Ear Infirmary, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA. HLKaufman@mgh.harvard.edu.
  • Division of Gastrointestinal and Oncologic Surgery, Department of Surgery, Massachusetts General Hospital, Boston, MA, USA. HLKaufman@mgh.harvard.edu.
Publications dans "Virus oncolytiques" :

Stephen J Russell

3 publications dans cette catégorie

Affiliations :
  • Department of Molecular Medicine, Mayo Clinic College of Medicine, Rochester, MN 55905, USA.
Publications dans "Virus oncolytiques" :

Yufeng Qiu

2 publications dans cette catégorie

Affiliations :
  • College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018, China.
Publications dans "Virus oncolytiques" :

Kan Chen

2 publications dans cette catégorie

Affiliations :
  • College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018, China.
Publications dans "Virus oncolytiques" :

Yanrong Zhou

2 publications dans cette catégorie

Affiliations :
  • College of Life Sciences and Medicine, Zhejiang Sci-Tech University, Hangzhou 310018, China.
Publications dans "Virus oncolytiques" :

Velia Penza

2 publications dans cette catégorie

Affiliations :
  • Department of Molecular Medicine, Mayo Clinic, Rochester, MN 55905, USA.
Publications dans "Virus oncolytiques" :

Christine E Engeland

2 publications dans cette catégorie

Affiliations :
  • Clinical Cooperation Unit Virotherapy, German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT) and Department of Medical Oncology, University Hospital Heidelberg, 69120 Heidelberg, Germany.
  • Center for Biomedical Education and Research (ZBAF), Institute of Virology and Microbiology, Faculty of Health, School of Medicine, Witten/Herdecke University, 58453 Witten, Germany.
Publications dans "Virus oncolytiques" :

Guy Ungerechts

2 publications dans cette catégorie

Affiliations :
  • Clinical Cooperation Unit Virotherapy, German Cancer Research Center (DKFZ), National Center for Tumor Diseases (NCT) and Department of Medical Oncology, University Hospital Heidelberg, 69120 Heidelberg, Germany.
Publications dans "Virus oncolytiques" :

Alberto Reale

2 publications dans cette catégorie

Affiliations :
  • Department of Molecular Medicine, University of Padua, 35121 Padua, Italy.
Publications dans "Virus oncolytiques" :

Arianna Calistri

2 publications dans cette catégorie

Affiliations :
  • Department of Molecular Medicine, University of Padua, 35121 Padua, Italy.
Publications dans "Virus oncolytiques" :

David M Miller

2 publications dans cette catégorie

Affiliations :
  • Division of Hematology/Oncology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Harvard Medical School, Harvard University, Boston, MA, USA.
  • Department of Dermatology, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
Publications dans "Virus oncolytiques" :

Nadishka Jayawardena

2 publications dans cette catégorie

Affiliations :
  • Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand.

John T Poirier

2 publications dans cette catégorie

Affiliations :
  • Department of Medicine and Molecular Pharmacology Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Laura N Burga

2 publications dans cette catégorie

Affiliations :
  • Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand.

Mihnea Bostina

2 publications dans cette catégorie

Affiliations :
  • Department of Microbiology and Immunology, University of Otago, Dunedin, New Zealand.
  • Otago Micro and Nano Imaging, University of Otago, Dunedin, New Zealand.

Ana Lemos de Matos

2 publications dans cette catégorie

Affiliations :
  • Biodesign Center for Immunotherapy, Vaccines, and Virotherapy (B-CIVV), The Biodesign Institute, Arizona State University, Tempe, AZ 85287, USA.
Publications dans "Virus oncolytiques" :

Sources (10000 au total)

Biology System Description Language (BiSDL): a modeling language for the design of multicellular synthetic biological systems.

The Biology System Description Language (BiSDL) is an accessible, easy-to-use computational language for multicellular synthetic biology. It allows synthetic biologists to represent spatiality and mul... BiSDL's effectiveness is showcased through three case studies on complex multicellular systems: a bacterial consortium, a synthetic morphogen system and a conjugative plasmid transfer process. These s... BiSDL represents a significant step forward in computational languages for synthetic biology, providing a sophisticated yet user-friendly tool for designing and simulating complex biological systems w...